10 provinces purchase 21 large varieties (list attached)

1.

On April 27, the Heilongjiang Medical Security Bureau issued the "Announcement of the "Eight Provinces and Two Districts" Medical Security Bureau on Carrying out the Centralized Procurement of Drugs by the Inter-provincial Alliance".

According to the notice, in accordance with the "Opinions of the General Office of the State Council on Promoting the Normalization and Institutionalization of Drug Centralized and Volume Procurement" (Guobanfa [2021] No.

The scope of participation includes the "eight provinces and two districts" public medical institutions and military medical institutions; other medical institutions shall be implemented in accordance with the relevant regulations of each alliance region.

This announcement is the first independent publication of Heilongjiang Province after joining the inter-provincial alliance, and it also signifies the beginning of a new form of provincial-level mass procurement.

2.

The procurement of the "eight provinces and two regions" led by Heilongjiang includes Heilongjiang, Inner Mongolia, Liaoning, Jilin, Shanxi, Hainan, Guizhou, Sichuan, Tibet, Qinghai, covering the entire Northeast, parts of the Northwest and other regions.

Among them, 21 major varieties are involved, including felodipine oral normal-release dosage forms, tropisetron injections, cefotiam injections, etc.

It is reported that felodipine, torasemide, fluorouracil, ozagrel sodium, sucrose iron injection, lidocaine, calcitriol, tranexamic acid injection, argatroban injection are all participating in the provincial belt for the first time.

Of the 21 large varieties that participated in volume procurement this time, nearly one-half of them participated in provincial-level volume procurement for the first time.

3.

It is worth noting that among the eight provinces and two districts this time, except for Guizhou and Qinghai, the other provinces or districts have participated in the “six provinces and two districts” of the Sichuan Union before, while Guizhou Province has participated in the "Four provinces, one city and one district" lead volume procurement, Qinghai Province has participated in the lead volume procurement of Shaanxi 10-province alliance.

On January 29, at the State Council's regular policy briefing, Chen Jinpu, deputy director of the National Medical Security Administration, emphasized that there must be alliances among local recruitment and procurement, and the provincial platform must be the center, and regional and cross-regional alliances are recommended.

Catalyzed by the policy, procurement of the "Alliance Edition" continues to accelerate, and alliance members continue to expand, and there is a constant overlap of multiple provinces.

This year, Hu Jinglin, director of the National Medical Insurance Administration, published an article "Promoting the high-quality development of medical security" and proposed to promote the institutionalization and normalization of centralized drug purchases, and in-depth exploration of the reform of the centralized procurement system for high-value medical consumables.

Previously, in the "six provinces and two districts" inter-provincial alliance led by the Sichuan Provincial Medical Security Bureau and Chengdu Medical Security Bureau, the average price of 11 selected drugs dropped by 58.

In general, the effect of drug price reduction under the national organization of centralized drug procurement, inter-provincial alliances, and provincial procurement nesting is obvious.
Of course, with the continuous acceleration of inter-provincial centralized procurement, the market threshold facing pharmaceutical companies in the future will continue to increase.